This article, published by Consulting.ca, discusses results from Buck’s 2019 Canadian Health Trend Survey, which showed that insurance providers’ pharmaceutical trend factor increases were significantly higher than increases in actual drug costs.
Related insights
Checklist: COVID-19 Compliance check-in
In 2021, employers are still feeling the impact of COVID-19 on their businesses, employees,...
Read moreSurvey: Compliance implications of the American Rescue Plan Act (ARPA) on employment, health, and welfare benefits
Employers and plan sponsors face challenges as they navigate the latest federal legislation intended...
Read moreSurvey: Talking to employees about vaccine hesitancy
Nearly one-third (30%) of U.S. employees plan to take a “wait and see” approach...
Read more